SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-14-076368
Filing Date
2014-12-30
Accepted
2014-12-30 14:21:29
Documents
2
Period of Report
2014-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 v397734_form3.html 3  
1 FORM 3 v397734_form3.xml 3 1652
2 EXHIBIT 24.1 v397734_ex24-1.htm EX-24.1 8318
  Complete submission text file 0001144204-14-076368.txt   11425
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 50 PRESCOTT STREET WORCESTER MA 01605
Business Address
DiPalma Stephen J. (Reporting) CIK: 0001426479 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32715 | Film No.: 141315592